Safety and Efficacy of Ianalumab in Patients With Sj?gren's Disease: 52-Week Results From a Randomized, Placebo-Controlled, Phase 2b Dose-Ranging Study
待确认10由 上上签 发布于 2026/6/18 16:15:36
DOI:10.1002/art.43059
作者:Thomas D?rner,?Simon J. Bowman,?Robert Fox,?Xavier Mariette,?Athena Papas,?Thomas Grader-Beck,?Benjamin A. Fisher,?Filipe Barcelos,?Salvatore De Vita,?Hendrik Schulze-Koops,?Robert J. Moots,?Guido Jun
文献类型:期刊论文
补充材料:只需要正文